- Home
- LYEL vs ITIC Comparison
LYEL vs ITIC Comparison
Compare LYEL & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LYEL | ITIC |
|---|---|---|
| Founded | 2018 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 431.1M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LYEL | ITIC |
|---|---|---|
| Price | $19.89 | $214.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $27.25 | N/A |
| AVG Volume (30 Days) | ★ 83.6K | 9.1K |
| Earning Date | 03-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.93% |
| EPS Growth | N/A | ★ 13.02 |
| EPS | N/A | ★ 18.57 |
| Revenue | $36,000.00 | ★ $272,755,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17,438.13 | N/A |
| P/E Ratio | ★ N/A | $11.53 |
| Revenue Growth | N/A | ★ 5.60 |
| 52 Week Low | $0.39 | $190.20 |
| 52 Week High | $45.00 | $288.98 |
Technical Indicators
Market Signals| Indicator | LYEL | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 40.46 | 33.64 |
| Support Level | $15.82 | $209.71 |
| Resistance Level | $27.30 | $221.39 |
| Average True Range (ATR) | 2.18 | 5.60 |
| MACD | -0.29 | 0.01 |
| Stochastic Oscillator | 27.78 | 18.70 |
Price Performance
Historical ComparisonAbout LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.